Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.
Clinical trial NCT03343847 · WITHDRAWN
Trial details
- NCT number
- NCT03343847
- Sponsor
- Amgen
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-27
- Primary completion
- 2021-07-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.